china medicine
Clinical Testing Of OncoCyte’s Bladder Cancer Diagnostics In China
OncoCyte Corporation has initiated clinical development of its PanC-Dx™ bladder cancer diagnostic test in both the United States and China.
OncoCyte Corporation has initiated clinical development of its PanC-Dx™ bladder cancer diagnostic test in both the United States and China.
